In hopeful sign for biotech, obesity treatment firm Kailera raises $625 million in upsized IPO
Kailera Therapeutics Inc., a clinical-stage biotechnology company focused on obesity, raised $625 million in an upsized initial public offering, marking the sector’s biggest US listing since 2021. The Waltham, Massachusetts-based company’s IPO priced at …